NYAMATA, Rwanda, September 27, 2010 - A little over a year since Rwanda introduced a pneumococcal known as PCV7. The vaccine protects children from one of the most common causes of pneumonia - with encouraging results. In Nyamata, located in Rwandas Bugesera area an hour from the capital Kigali, both residents and health professionals recognize that significant changes have occurred. The level of hospitalizations for pneumonia among children has declined, says Dr. Darius Mukamusoni, director Nyamatas hospital, adding however that the vaccine was introduced a year ago its full impact is still difficult to assess. She stressed that more educated parents, the less the likelihood that their children strattera online will be reduced pneumonia. Rwanda introduced PCV7 in April 2009 with the support of UNICEF and the Global Alliance for Vaccines and Immunization (HAVI), and the generous donation from Wyeth Corporation. UNICEF HAVI and other partners to work with the Rwandan Ministry of Health to strengthen systems for the delivery of child health. This, in turn, has allowed Rwanda to be one of the first developing countries to benefit from PCV7. Many private partners are also working to deliver vaccines where they are most needed to help countries take steps to achieve the Millennium Development United Nations goals related to children's health. Earlier this year Bill Melinda Gates Foundation announced that it will make investments of $ 10 billion over the next 10 years to immunization. .
